In vitro-digested milk proteins: Evaluation of angiotensin-1-converting enzyme inhibitory and antioxidant activities, peptidomic profile, and mucin gene expression in HT29-MTX cells.
Angiotensin-Converting Enzyme Inhibitors
/ chemistry
Animals
Antioxidants
/ metabolism
Caseins
/ metabolism
Chromatography, Liquid
Digestion
Gene Expression
HT29 Cells
Humans
Milk
/ metabolism
Milk Proteins
/ metabolism
Mucins
/ genetics
Peptidyl-Dipeptidase A
/ metabolism
Soybean Proteins
/ metabolism
Tandem Mass Spectrometry
Whey
/ metabolism
angiotensin-I-converting enzyme
in vitro digestion
milk protein
peptidomics
Journal
Journal of dairy science
ISSN: 1525-3198
Titre abrégé: J Dairy Sci
Pays: United States
ID NLM: 2985126R
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
20
04
2019
accepted:
16
07
2019
pubmed:
16
9
2019
medline:
29
1
2020
entrez:
16
9
2019
Statut:
ppublish
Résumé
Over the past decades, several studies investigated the health-promoting functions of milk peptides. However, to date many hurdles still exist regarding the widespread use of milk-derived bioactive peptides, as they may be degraded during gastrointestinal digestion. Thus, the aim of our study was to in vitro digest intact whey protein isolate (WPI) and casein proteins (CNP), mimicking in vivo digestion, to investigate their bioactive effects and to identify the potential peptides involved. Whey protein isolate and CNP were digested using a pepsin-pancreatin protocol and ultra-filtered (3-kDa cutoff membrane). A permeate (<3 kDa) and a retentate (>3 kDa) were obtained. Soy protein was included as a control (CTR). Angiotensin-1-converting enzyme inhibitory (ACE1-I) and antioxidant activity (AOX) were assessed and compared with those observed in undigested proteins and CTR. Furthermore, the permeate was characterized by nano-liquid chromatography electrospray ionization tandem mass spectrometry (LC-nano ESI MS/MS) using a shotgun peptidomic approach, and retentate was further digested with trypsin and analyzed by MS using a shotgun proteomic approach to identify potentially bioactive peptides. Further, the effects of WPI, CNP, and CTR retentate on cell metabolic activity and on mucus production (MUC5AC and MUC2 gene expression) were assessed in intestinal goblet HT29-MTX-E12 cells. Results showed that WPI permeate induced a significant ACE1-I inhibitory effect [49.2 ± 0.64% (SEM)] compared with undigested WPI, CNP permeate, and retentate or CTR permeate (10.40 ± 1.07%). A significant increase in AOX (1.58 ± 0.04 and 1.61 ± 0.02 µmol of trolox AOX equivalents per mg of protein, respectively) upon digestion was found in WPI. Potentially bioactive peptides associated with ACE1-I and antihypertensive effects were identified in WPI permeate and CNP retentate. At specific concentrations, WPI, CNP, and CTR retentate were able to stimulate metabolic activity in HT29-MTX-E12 cells. Expression of MUC5AC was increased by CNP retentate and unaltered by WPI retentate; MUC2 expression was significantly increased by 0.33 mg/g of CNP and reduced by 1.33 mg/g of CNP. Our results confirm that milk proteins may be rich sources of bioactive compounds, with the greatest beneficial potential of CNP at the intestinal goblet cell level.
Identifiants
pubmed: 31521344
pii: S0022-0302(19)30807-0
doi: 10.3168/jds.2019-16833
pii:
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Antioxidants
0
Caseins
0
Milk Proteins
0
Mucins
0
Soybean Proteins
0
Peptidyl-Dipeptidase A
EC 3.4.15.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10760-10771Informations de copyright
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.